Tian'an Technology (TANAF) Debt to Equity (2022 - 2025)

Tian'an Technology (TANAF) posted Debt to Equity of -$0.18 for Q4 2025, up 92.77% on a QoQ basis from -$2.5 in Q2 2025, and down 102.48% year-over-year from $7.27 in Q4 2024.

Tian'an Technology (TANAF) has 4 years of Debt to Equity data on file, last reported at -$0.18 in Q4 2025.

  • In Q4 2025, Debt to Equity fell 102.48% year-over-year to -$0.18; the TTM figure through Dec 2025 stood at -$0.18 (down 102.48% YoY), while the FY2025 annual figure was -$0.18, down 102.48% from the prior year.
  • Debt to Equity climbed to -$0.18 in Q4 2025, from -$2.5 in the prior quarter.
  • Across five years, Debt to Equity topped out at $7.27 in Q4 2024 and bottomed at -$2.5 in Q2 2025.
  • A 4-year average of $0.49 and a median of -$0.18 in 2025 frame the typical range for Debt to Equity.
  • Annual changes were most pronounced in 2023 — Debt to Equity tumbled 703.85% — and 2024, when it surged 1178.14%.
  • Year by year, Debt to Equity stood at -$0.08 in 2022, then tumbled by 703.85% to -$0.67 in 2023, then surged by 1178.14% to $7.27 in 2024, then tumbled by 102.48% to -$0.18 in 2025.
  • The last three Debt to Equity figures came in at -$0.18 (Q4 2025), -$2.5 (Q2 2025), and $7.27 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Tian'an Technology - - - -0.18

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -0.18
Jun 30, 2025 -2.50
Dec 31, 2024 7.27
Jun 30, 2024 -0.51
Dec 31, 2023 -0.06
Jun 30, 2023 -0.09
Dec 31, 2022 -0.08